oppn parties Doctors & Pharma Companies Make Hay While Regulators Sleep and Patients Suffer

News Snippets

  • Kapil Sibal leaves Congress, fills nomination for Rajya Sabha with SPs backing
  • RBI bans 5 NBFCs as it cracks down on e-lending platforms
  • Hindustan Motors to tie-up with Peugeot to bring out a redesigned version of the iconic Ambassador
  • GST Council to defer rate rejig due to inflation
  • Centre to sell 29.5% in Hindustan Zinc at an expected price of Rs 38000cr
  • Stocks remain negative on Wednesday: Sensex loses 303 points to 53749 and Nifty 99 to 16025
  • IPL: RCB beat LSG by 14 runs and end their dream run. Rajat Patidar scores a brilliant 112. RCB will take on RR to decide who goes through to the finals
  • Delhi Additional district judge Nikhil Chopra says there is no legal right for people seeking to worship deity inside Qutab Minar, says it survived 800 years without worship so "let it survive like that"
  • Punjab chief minister Bhagwant Mann sacks state health minister Vijay Singla over corruption charges. Singla was later arrested by the ACB
  • Protestors burn the house of Andhra minister P Viswaroop and MLA Satish Kumar over renaming of Konaseema district as B R Amberdkar Konaseema
  • Gyanvapi: Varanasi district judge decides to first hear the 'maintainability' plea filed by mosque management
  • Delhivery and Venus Pipes shares list at premium of 10% and 8.7% respectively even when market sentiment was down
  • In a bid to cool edible oil prices, Centre allows duty-free imports of 20 lakh tonnes each of crude sunflower oil and crude palm oil per annum this year and next
  • Centre caps sugar exports to ensure availability of stocks in the domestic markets to cool prices
  • Stock markets get the jitters as RBI signals rate hike and government moves in to control inflation: Sensex tumbles by 236 points to 54052 and Nifty goes down by 89 points to 16125
Yasin Malik of JKLF gets two life terms in terror funding case /////// Kashmir TV artist killed and her nephew injured in a terror attack in Hushroo in Budgam district
oppn parties
Doctors & Pharma Companies Make Hay While Regulators Sleep and Patients Suffer

By Linus Garg
First publised on 2020-02-24 19:33:53

About the Author

Sunil Garodia Linus tackles things head-on. He takes sides in his analysis and it fits excellently with our editorial policy. No 'maybe's' and 'allegedly' for him, only things in black and white.

The Income Tax Department, deposing in a tax dispute case in the Madras High Court, has submitted that more than 8600 pharmaceutical companies had claimed deductions for freebies given to doctors under the heads "sales promotion expenses" and "gifts" in the last assessment year. This is despite the fact that providing such freebies or any kind of inducement to doctors to prescribe drugs of a particular brand is prohibited by law. This matter has been regularly grabbing headlines without a solution being found. Neither the self-imposed guidelines (grandiosely named Uniform Code for Pharmaceutical Marketing Practices) of the pharmaceuticals industry nor the presence of associations and regulatory bodies have made such companies stop the practice.

Considerable outrage had erupted when an NGO, Support for Advocacy and Training to Health Initiatives (SATHI), had published a report in August last year which highlighted the unethical marketing practices by companies and its gleeful acceptance by many doctors. The report confirmed (although it is common knowledge for many years) that pharma companies provided doctors with gifts ranging from laptops, cars and foreign holidays to even services of women for prescribing their brands. The report had even caught the attention of Prime Minister Modi who had then asked pharma companies not to give gifts to doctors. But there is no evidence to suggest that they have heeded his advice.

In 2014, the erstwhile Medical Council of India had summoned 300 doctors from across the country to answer charges of having been "bribed" by a pharmaceutical company. Less than half appeared although the charge was very serious. It was found that an Ahmedabad-based company had bribed the doctors by offering them cash rewards, cars, flats, and foreign trips for prescribing its brand of drug formulations. This was apparent from the fact that the sales of the company zoomed from zero to Rs 500 crore in just five years. Moreover, such practices went on despite the fact that the same drug formulations were available in the market at cheaper rates from well-known companies as Cipla, Ranbaxy, Sun, Aristo, Alkem, Zydus, and Cadila. Nothing much came out of the hearings as the MCI, as was its habit, just rapped the knuckles of errant doctors without suspending their licenses. Suffice to say, the offense continues with gay abundance.

The government must act in multiple ways to curb this practice which is unethical as well as dangerous. Doctors who choose to be agents of pharma companies often prescribe unnecessary and costly drugs, including antibiotics, just to 'earn' commission. There was a proposal to make it mandatory for doctors to prescribe medicines by their generic names and not by brand names. But it never saw the light of day, ostensibly due to the pressure tactics of the powerful cartel of big pharma companies. There is also a drawback in writing prescriptions with generic names - the commission that is now being paid to doctors will be then paid to the chemist or pharmacy owner who will then push the brand that offers them the heftiest margin. Hence, there is no easy solution to the problem and the government must think of out of the box to stop this unethical marketing practice.